310 related articles for article (PubMed ID: 31731456)
21. Phosphoproteome analysis of cerebrospinal fluid extracellular vesicles in primary central nervous system lymphoma.
Deng Y; Li Q; Sun J; Ma L; Ding Y; Cai Y; Iliuk A; Chen B; Xie Z; Tao WA
Analyst; 2023 Jul; 148(15):3594-3602. PubMed ID: 37403840
[TBL] [Abstract][Full Text] [Related]
22. Challenges and standardization of microRNA profiling in serum and cerebrospinal fluid in dogs suffering from non-infectious inflammatory CNS disease.
Cirera S; Andersen-Ranberg EU; Langkilde S; Aaquist M; Gredal H
Acta Vet Scand; 2019 Dec; 61(1):57. PubMed ID: 31796072
[TBL] [Abstract][Full Text] [Related]
23. Primary Central Nervous System Lymphomas: A Diagnostic Overview of Key Histomorphologic, Immunophenotypic, and Genetic Features.
Lauw MIS; Lucas CG; Ohgami RS; Wen KW
Diagnostics (Basel); 2020 Dec; 10(12):. PubMed ID: 33322508
[TBL] [Abstract][Full Text] [Related]
24. Expression of Tim-1 in primary CNS lymphoma.
Kishimoto W; Nishikori M; Arima H; Miyoshi H; Sasaki Y; Kitawaki T; Shirakawa K; Kato T; Imaizumi Y; Ishikawa T; Ohno H; Haga H; Ohshima K; Takaori-Kondo A
Cancer Med; 2016 Nov; 5(11):3235-3245. PubMed ID: 27709813
[TBL] [Abstract][Full Text] [Related]
25. MicroRNA Biomarkers in Canine Diffuse Large B-Cell Lymphoma.
Elshafie NO; Nascimento NCD; Lichti NI; Kasinski AL; Childress MO; Santos APD
Vet Pathol; 2021 Jan; 58(1):34-41. PubMed ID: 33287683
[TBL] [Abstract][Full Text] [Related]
26. Circulating microRNA-125b and microRNA-130a expression profiles predict chemoresistance to R-CHOP in diffuse large B-cell lymphoma patients.
Yuan WX; Gui YX; Na WN; Chao J; Yang X
Oncol Lett; 2016 Jan; 11(1):423-432. PubMed ID: 26870228
[TBL] [Abstract][Full Text] [Related]
27. High-throughput quantitation of amino acids and acylcarnitine in cerebrospinal fluid: identification of PCNSL biomarkers and potential metabolic messengers.
Ma J; Chen K; Ding Y; Li X; Tang Q; Jin B; Luo RY; Thyparambil S; Han Z; Chou CJ; Zhou A; Schilling J; Lin Z; Ma Y; Li Q; Zhang M; Sylvester KG; Nagpal S; McElhinney DB; Ling XB; Chen B
Front Mol Biosci; 2023; 10():1257079. PubMed ID: 38028545
[No Abstract] [Full Text] [Related]
28. Effectiveness of digital PCR for MYD88
Chen K; Ma Y; Ding T; Zhang X; Chen B; Guan M
Exp Ther Med; 2020 Jul; 20(1):301-308. PubMed ID: 32536998
[TBL] [Abstract][Full Text] [Related]
29. Circulating microRNAs in Cerebrospinal Fluid and Plasma: Sensitive Tool for Detection of Secondary CNS Involvement, Monitoring of Therapy and Prediction of CNS Relapse in Aggressive B-NHL Lymphomas.
Krsmanovic P; Mocikova H; Chramostova K; Klanova M; Trnkova M; Pesta M; Laslo P; Pytlik R; Stopka T; Trneny M; Pospisil V
Cancers (Basel); 2022 May; 14(9):. PubMed ID: 35565434
[TBL] [Abstract][Full Text] [Related]
30. Intratumor heterogeneity and T cell exhaustion in primary CNS lymphoma.
Heming M; Haessner S; Wolbert J; Lu IN; Li X; Brokinkel B; Müther M; Holling M; Stummer W; Thomas C; Schulte-Mecklenbeck A; de Faria F; Stoeckius M; Hailfinger S; Lenz G; Kerl K; Wiendl H; Meyer Zu Hörste G; Grauer OM
Genome Med; 2022 Sep; 14(1):109. PubMed ID: 36153593
[TBL] [Abstract][Full Text] [Related]
31. A differentially expressed set of microRNAs in cerebro-spinal fluid (CSF) can diagnose CNS malignancies.
Drusco A; Bottoni A; Laganà A; Acunzo M; Fassan M; Cascione L; Antenucci A; Kumchala P; Vicentini C; Gardiman MP; Alder H; Carosi MA; Ammirati M; Gherardi S; Luscrì M; Carapella C; Zanesi N; Croce CM
Oncotarget; 2015 Aug; 6(25):20829-39. PubMed ID: 26246487
[TBL] [Abstract][Full Text] [Related]
32. Clinicopathological features, survival and prognostic factors of primary central nervous system lymphomas: trends in incidence of primary central nervous system lymphomas and primary malignant brain tumors in a well-defined geographical area. Population-based data from the Danish Lymphoma Registry, LYFO, and the Danish Cancer Registry.
Krogh-Jensen M; D'Amore F; Jensen MK; Christensen BE; Thorling K; Pedersen M; Johansen P; Boesen AM; Andersen E
Leuk Lymphoma; 1995 Oct; 19(3-4):223-33. PubMed ID: 8535213
[TBL] [Abstract][Full Text] [Related]
33. Micro RNAs as a Diagnostic Marker between Glioma and Primary CNS Lymphoma: A Systematic Review.
Dabbagh Ohadi MA; Aleyasin MS; Samiee R; Bordbar S; Maroufi SF; Bayan N; Hanaei S; Smith TR
Cancers (Basel); 2023 Jul; 15(14):. PubMed ID: 37509289
[TBL] [Abstract][Full Text] [Related]
34. Preferential up-regulation of osteopontin in primary central nervous system lymphoma does not correlate with putative receptor CD44v6 or CD44H expression.
Yuan J; Gu K; He J; Sharma S
Hum Pathol; 2013 Apr; 44(4):606-11. PubMed ID: 23089492
[TBL] [Abstract][Full Text] [Related]
35. Current strategies in the diagnosis of diffuse large B-cell lymphoma of the central nervous system.
Baraniskin A; Deckert M; Schulte-Altedorneburg G; Schlegel U; Schroers R
Br J Haematol; 2012 Feb; 156(4):421-32. PubMed ID: 22077417
[TBL] [Abstract][Full Text] [Related]
36. MYC, BCL2, and BCL6 rearrangements in primary central nervous system lymphoma of large B cell type.
Nosrati A; Monabati A; Sadeghipour A; Radmanesh F; Safaei A; Movahedinia S
Ann Hematol; 2019 Jan; 98(1):169-173. PubMed ID: 30306208
[TBL] [Abstract][Full Text] [Related]
37. CSF interleukin 6 is a useful marker to distinguish pseudotumoral CNS inflammatory diseases from primary CNS lymphoma.
Ungureanu A; Le Garff-Tavernier M; Costopoulos M; Parratte T; Brinet A; Durand H; Gaultier C; Hurstel R; Alamome I; Sellal F; Ahle G
J Neurol; 2021 Aug; 268(8):2890-2894. PubMed ID: 33609156
[TBL] [Abstract][Full Text] [Related]
38. High Level of IL-10 in Cerebrospinal Fluid is Specific for Diagnosis of Primary Central Nervous System Lymphoma.
Shao J; Chen K; Li Q; Ma J; Ma Y; Lin Z; Kang H; Chen B
Cancer Manag Res; 2020; 12():6261-6268. PubMed ID: 32801871
[TBL] [Abstract][Full Text] [Related]
39. A Multiplex Assay for the Stratification of Patients with Primary Central Nervous System Lymphoma Using Targeted Mass Spectrometry.
Waldera-Lupa DM; Poschmann G; Kirchgaessler N; Etemad-Parishanzadeh O; Baberg F; Brocksieper M; Seidel S; Kowalski T; Brunn A; Haghikia A; Gold R; Stefanski A; Deckert M; Schlegel U; Stühler K
Cancers (Basel); 2020 Jun; 12(7):. PubMed ID: 32610669
[TBL] [Abstract][Full Text] [Related]
40. MicroRNAs are suitable for assessment as biomarkers from formalin-fixed paraffin-embedded tissue, and miR-24 represents an appropriate reference microRNA for diffuse large B-cell lymphoma studies.
Culpin RE; Sieniawski M; Proctor SJ; Menon G; Mainou-Fowler T
J Clin Pathol; 2013 Mar; 66(3):249-52. PubMed ID: 23172553
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
